October 11, 2024 08:00 Non Regulatory Invitation to presentation and Q&A of Flerie’s Q3 2024 interim report Read news release
October 7, 2024 Microbiotica Announces First Patient Dosed in its International Phase 1b Trial, MELODY-1 of MB097 Precision Microbiome Co-Therapy in Advanced Melanoma Read news release
October 2, 2024 Toleranzia submits a clinical trial application (CTA) for the drug candidate TOL2 for the treatment of myasthenia gravis Read news release
October 2, 2024 NorthX Biologics strengthens leadership team with Magnus Gustafsson as Chief Commercial Officer Read news release
